免疫性角膜病:参考文献

  • 1. Giese MJ,Adamu SA,Pitchekian-Halabi H,et al. The effect of Staphylococcus aureus phage lysate vaccine on a rabbit model of staphylococcal blepharitis,phlyctenulosis,and catarrhal infiltrates. Am J Ophthalmol,1996,122:245-254.
  • 2. Schwartz GS,Harrison AR,Holland EJ. Etiology of immune stromal (interstitial) keratitis. Cornea,1998,17:278-281.
  • 3. Holland EJ,Schwartz GS. Classification of herpes simplex virus keatitis. Cornea,1999,18:144-154.
  • 4. 谢立信. 角膜移植学 . 北京:人民卫生出版社,2000.
  • 5. Wall V,Yen MT,Yang MC,et al. Management of the late ocular sequelae of Stevens-Johnson syndrome. Ocul Surf,2003,1:192-201.
  • 6. Watson,SL,Hollingsworth,J,Tullo,AB. Confocal microscopy of Thygeson’s superficial punctate keratopathy. Cornea,2003,22 :294-299.
  • 7. Tabery HM. Filamentary keratopathy:a non-contact photomicrographic in vivo study in the human cornea. Eur J Ophthalmol,2003,13:599-605.
  • 8. Orsoni JG,Zavota L,Manzotti F,et al. Syphilitic interstitial keratitis:treatment with immunosuppressive drug combination therapy,Cornea,2004,23:530-532.
  • 9. Nagra PK,Rapuano CJ,Cohen EJ,et al. Thygeson’s superficial punctate keratitis - Ten years’experience. Opthalmology,2004,111:34-37.
  • 10. Ono SJ,Abelson MB. Allergic conjunctivitis:Update on pathophysiology and prospects for future treatment . J Allergy Clin Immun,2005,115:118-122.
  • 11. Tatlipinar S,Akpek EK. Topical ciclosporin in the treatment of ocular surface disorders. Br J Opthalmol,2005,89:1363-1367.
  • 12. Wilhelmus KR,Jones DB. Adult-onset syphilitic stromal keratitis. Am J Ophthalmol. 2006,141:319-321.
  • 13. Kafkala C,Choi J,Zafirakis P,et al. Mooren ulcer:an immunopathologic study. Cornea,2006,25:667-673.
  • 14. Kumagai N,Fukuda K ,Fujitsu Y,et al. Role of structural cells of the cornea and conjunctiva in the pathogenesis of vernal keratoconjunctivitis. Prog Retin Eye Res,2006,25:165-187.
  • 15. Daniell M,Constantinou M,Vu HT,et al. Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis. Br J Opthalmol,2006,90 :461-464.
  • 16. Fukushima A,Yamaguchi T,Ishida W,et al. Cyclosporin A inhibits eosinophilic infiltration into the conjunctiva mediated by type IV allergic reactions. Clin Exp Opthalmol,2006,34 :347-353.
  • 17. Connell PP,O'Reilly J,Coughlan S,et al The role of common viral ocular pathogens in Thygeson’s superficial punctate keratitis. Br J Opthalmol,2007,91:1038-1041.
  • 18. Duszak,Robert S. Diagnosis and management of Thygeson’s superficial punctate keratitis. Optometry,2007,78:333-338.
  • 19. 谢立信,史伟云. 角膜病学 . 北京:人民卫生出版社,2007.
  • 20. 李莹,译,谢立信,审. 角膜理论基础与临床实践. 天津:天津科技翻译出版社,20007.
  • 21. De Rojas MV,Dart JK,Saw VP. The natural history of Stevens Johnson syndrome:patterns of chronic ocular disease and the role of systemic immunosuppressive therapy. Br J Ophthalmol,2007,91:1048-1053.
  • 22. Mantelli F,Santos MS,Petitti T,et al. Systematic review and meta-analysis of randomised clinical trials on topical treatments for vernal keratoconjunctivitis. Br J Opthalmol,2007,97:1656-1661.
  • 23. Dogru M,Kato N,Matsumoto Y,et al. Immunohistochemistry and electron microscopy of retrocorneal scrolls in syphilitic interstitial keratitis. Curr Eye Res,2007,32:863-870.
  • 24. Yip LW,Thong BY,Lim J,et al. Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis:an Asian series. Allergy,2007,62:527-531.
  • 25. Diebold Y,Chen LL,Tepavcevic V,Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas (lpr) mouse model of Sjögren’s syndrome. Exp Eye Res,2007,84:500-512.
  • 26. Hyon JY,Lee YJ,Yun PY. Management of ocular surface inflammation in Sjögren syndrome. Cornea,2007,26:S13-15.
  • 27. Shen YC,Wang CY,Chen YC,et al. Progressive herpetic linear endotheliitis. Cornea,2007,26:365-367.
  • 28. Kocabeyoglu S,Bozkurt B,Bilen O,et al. Serum allergen specific immunoglobulin E levels in patients with allergic conjunctivitis. Eur J Opthalmoll,2008, 18:675-679.
  • 29. Tandon R,Chawla B,Verma K,et al. Outcome of treatment of mooren ulcer with topical cyclosporine a 2%. Cornea,2008,27(8):859-861.
  • 30. Koizumi N,Suzuki T,Uno T,et al. Cytomegalovirus as an etiologic factor in corneal endotheliitis. Ophthalmology,2008,115:292-297.
  • 31. Ueta M,Tokunaga K,Sotozono C,et al. HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese. Mol Vis,2008,17:550-555.
  • 32. Liu C,Okera S,Tandon R,et al. Visual rehabilitation in end-stage inflammatory ocular surface disease with the osteo-odonto-keratoprosthesis:results from the UK. Br J Ophthalmol,2008,92:1211-1217.
  • 33. Kawamoto K,Chikama T,Takahashi N,et al. In vivo observation of Langerhans cells by laser confocal microscopy in Thygeson’s superficial punctate keratitis. Mol Vis,2009,15:1456-1462.
  • 34. Fukuda K,Ohbayashi M,Morohoshi K,et al. Critical role of IgE-dependent mast cell activation in a murine model of allergic conjunctivitis. J Allergy Clin Immun,2009,124:827-833.
  • 35. Burmy S,Patel H,Rutner D. Adolescent interstitial keratitis secondary to intrauterine TB exposure. Optometry,2009,80:307.
  • 36. Gueudry J,Roujeau JC,Binaghi M,et al. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis. Arch Dermatol,2009,145:157-162.
  • 37. Hwang YS,Hsiao CH,Tan HY,et al. Corneal endotheliitis. Ophthalmology,2009,116:164-164.
  • 38. Sotozono C,Ueta M,Koizumi N,et al. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications. Ophthalmology,2009,116:685-690.
  • 39. Araki Y,Sotozono C,Inatomi T,et al. Successful treatment of Stevens-Johnson syndrome with steroid pulse therapy at disease onset. Am J Ophthalmol,2009,147:1004-1011.
  • 40. Phillips EJ,Mallal SA. HLA and drug-induced toxicity. Curr Opin Mol Ther. 2009 ,11:231-242.
  • 41. Nguyen CQ,Peck AB. Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease. Ocul Surf,2009,7:11-27.
  • 42. Wetter DA,Camilleri MJ. Clinical,etiologic,and histopathologic features of Stevens-Johnson syndrome during an 8-year period at Mayo Clinic. Mayo Clin Proc,2010,85(2):131-138.
  • 43. Kumar Sunil,Gupta N,Vivian AJ. Modern approach to managing vernal keratoconjunctivitis. Curr Allergy Asthma Rep,2010,10:155-162.
  • 44. Gelardi M,Spadavecchia L,Fanelli P,et al. Nasal inflammation in vernal keratoconjunctivitis. J Allergy Clin Immun,2010,125:496-498.
  • 45. Sacchetti M,Lambiase A,Mantelli F,et al. Tailored Approach to the Treatment of Vernal Keratoconjunctivitis. Opthalmology,2010,117:1294-1299.
  • 46. Kim SH,Ye YM,Palikhe NS,et al. Genetic and ethnic risk factors associated with drug hypersensitivity. Curr Opin Allergy Clin Immunol,2010,10:280-290.
  • 47. Akpek EK,Klimava A,Thorne JE,et al. Evaluation of patients with dry eye for presence of underlying Sjögren syndrome.Cornea,2009,28:493-497.

系统医学科普站点:天山医学院, 转载请注明出处:https://www.tsu.tw/edu/6329.html

小程序

内容拓展

中华皮肤病30年研究成果

心电图学一学就会

认识人体心脏,从解剖开始!

诱发心血管疾病的综合征

近视屈光激光手术矫正

适用于口腔科

做一个健康强健的男人!

智齿为萌出受阻的牙齿

内分泌与机体代谢医学